SCNX: scienture.com Long-Term Loans to Capital Ratio

Patent protection of IT infrastructure and high switching costs create a robust moat for Scienture Holdings Inc (SCNX). On GURU.Markets, this line chart of the long-term debt-to-equity ratio demonstrates market dynamics where the value of 0.15 reflects this status. Stable administrative resources and ISO compliance strengthen its position, while premium pricing for unique drug delivery methods ensures high margins.

This metric determines the dependence of long-term financing on the volume of equity, reflecting the operational resilience of the business. The indicator measures the share of loans with a maturity of over one year relative to equity to assess financial leverage. Scienture Holdings Inc (SCNX), as a medical software developer, minimizes environmental risks and capital expenditures on production. This allows the company to maintain a low level of borrowing. The trend in the ratio of liabilities over one year to equity confirms the issuer's margin of safety.